Leerink Partners analyst Marc Goodman reiterated a Buy rating on Avadel Pharmaceuticals (AVDL – Research Report) on November 12 and set a ...

Discover the top sales and marketing intelligence solutions tailored for the pharmaceutical industry. Download our guide to predictive analytics and data-driven insights.

It came as AZ reported its third-quarter results, headlined by a 20% increase in revenues to $12.95 billion, which will be ...

Citi analyst David Lebowitz raised the firm’s price target on Mirum Pharmaceuticals (MIRM ... handily beating Street estimates based on stronger than expected Livmarli sales, the analyst tells ...

Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an ...

By leveling up their streaming campaigns, advertisers can achieve big lifts in awareness and sales of their medications among ...

Amazon is winning the U.S. price wars, leaving Walmart and Target behind for the eighth consecutive year. The e-commerce ...

The country contributed $5.05 billion in sales in the first nine months of 2024, or 13% of the British pharma’s total haul of ...

Bayer cut its full-year earnings outlook after it posted a third-quarter net loss that significantly missed consensus ...

On Wednesday, Zentalis Pharmaceuticals Inc (ZNTL) stock saw a modest uptick, ending the day at $3.92 which represents a slight increase of $0.21 or 5.66% from the prior close of $3.71. The stock ...

Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 1475 in its research report ...

Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1532 in its research report dated 1, 2024.